- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01319162
Prevalence of Polycystic Ovary Syndrome (PCOS) in Obese Premenopausal Women
To Estimate the Prevalence of PCOS in Obese Premenopausal Women and Elucidate How They Respond to a Weight Reduction Treatment Program
Between 40% and 85% of women with Polycystic Ovary Syndrome (PCOS) are overweight or obese and obesity is closely linked to the development of PCOS. Although it is well established that obesity increases the severity of the clinical features of PCOS, data regarding the prevalence of PCOS in obese women and the change in body weight in women with PCOS over time are scares. In a prevalence study it was investigated whether obesity increases the risk of PCOS in the general population and they demonstrated that the prevalence rate of PCOS in underweight, normal-weight, overweight, and obese women were 8.2, 9.8, 9.9, and 9.0%, respectively, similar to that observed in the general population. These results suggest that the risk of PCOS is only minimally increased with obesity. On the other hand, in a Spanish prevalence study among overweight and obese subjects, they demonstrated a 28.3% prevalence of PCOS, which is markedly higher compared with the 5.5% prevalence of PCOS in lean women in Spain.
First the investigators aim to estimate the prevalence/probability of PCOS among obese, premenopausal women (between 18 and 50 years) with no symptoms of classic menopausal symptoms in Sweden. Secondly, to elucidate whether women diagnosed with PCOS respond to standard weight reduction regime to the same extent as women without PCOS.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
-
Göteborg, Schweden, 41345
- Sahlgrenska Obesity Center at Sahlgrenska University hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
PCOS diagnostic criteria should be the presence of both clinical and/or biochemical hyperandrogenism and/or oligo-/amenorrhea and/or polycystic ovaries (PCO).
Exclusion Criteria:
- Exclusion of other endocrine disorders such as hyperprolactinemia (s-prolactin < 27µg/L), nonclassic congenital adrenal hyperplasia (17-hydroxyprogesterone < 3nmol/L), and androgen secreting tumors.
- Pregnancy or breastfeeding the last 6 months.
- Any sign of climacteric symptoms.
- Language barrier or disabled person with reduced ability to understand information.
- Oral contraceptives and insulin sensitizing agents is commonly used among women with PCOS since it may interfere with hormone profile. As the prevalence of PCOS can be assumed to be increased among women using oral contraceptives and insulin sensitizing agents, they are included but analyzed separately.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
---|---|
Women with PCOS
All obese women between 18 and 50 years diagnosed with PCOS referred to a weight reduction treatment program at the Sahlgrenska Obesity Center at Sahlgrenska University hospital
|
The dietary intervention begins with a 12-weeks VLCD/LCD period.
The diet comprise of 3 to 5 portions liquid diet with a daily energy intake of 450-800 kcal.
In addition, patients will be encouraged to drink 1,5-2L daily of non-caloric beverages (<6 kcal/100 ml).
All patients will have scheduled nurse visits at week 0 (baseline), 2, 5, 8, and 12.
At these visits general well-being and body weight will be monitored.
The patient will also be given support and counselling to enhance compliance to the VLCD/LCD diet.
|
Women without PCOS
All obese women between 18 and 50 years not diagnosed with PCOS referred to a weight reduction treatment program at the Sahlgrenska Obesity Center at Sahlgrenska University hospital
|
The dietary intervention begins with a 12-weeks VLCD/LCD period.
The diet comprise of 3 to 5 portions liquid diet with a daily energy intake of 450-800 kcal.
In addition, patients will be encouraged to drink 1,5-2L daily of non-caloric beverages (<6 kcal/100 ml).
All patients will have scheduled nurse visits at week 0 (baseline), 2, 5, 8, and 12.
At these visits general well-being and body weight will be monitored.
The patient will also be given support and counselling to enhance compliance to the VLCD/LCD diet.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Prevalence/probability of PCOS among obese, premenopausal women (between 18 and 50 years) with no symptoms of classic menopausal symptoms in Sweden.
Zeitfenster: Within one month after first visit
|
Screening for PCOS among obese women includes menstrual history, clinical and biochemical signs of hyperandrogenism and polycystic ovaries on ultrasound measure in women with one of signs included in the diagnosis of the syndrome.
|
Within one month after first visit
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Response to weight reduction regime among obese women with and without PCOS
Zeitfenster: One year after inclusion
|
One year after inclusion
|
Food frequency
Zeitfenster: Within one month after measure
|
Within one month after measure
|
Health Related Quality of Life
Zeitfenster: Screening and one year later
|
Screening and one year later
|
Symptoms of anxiety and depression
Zeitfenster: Screening and after one year
|
Screening and after one year
|
Changes in sex steroids and other related hormones
Zeitfenster: Screening and after 1 year
|
Screening and after 1 year
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Kataoka J, Larsson I, Lindgren E, Kindstrand LO, Schmidt J, Stener-Victorin E. Circulating Anti-Mullerian hormone in a cohort-study of women with severe obesity with and without polycystic ovary syndrome and the effect of a one-year weight loss intervention. Reprod Biol Endocrinol. 2022 Oct 29;20(1):153. doi: 10.1186/s12958-022-01022-0.
- Kataoka J, Larsson I, Bjorkman S, Eliasson B, Schmidt J, Stener-Victorin E. Prevalence of polycystic ovary syndrome in women with severe obesity - Effects of a structured weight loss programme. Clin Endocrinol (Oxf). 2019 Dec;91(6):750-758. doi: 10.1111/cen.14098. Epub 2019 Oct 1.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- Prevalence-PCOS-Obesity
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur PCO-Syndrom
-
University of Colorado, DenverRekrutierungKlinefelter-Syndrom | Trisomie X | XYY-Syndrom | XXXY- und XXXXY-Syndrom | Xxyy-Syndrom | Xyyy-Syndrom | Xxxx-Syndrom | Xxxxx-Syndrom | Xxxyy-Syndrom | Xxyyy-Syndrom | Xyyyy-Syndrom | Männchen mit GeschlechtschromosomenmosaikVereinigte Staaten
-
Riphah International UniversityAbgeschlossen
-
Riphah International UniversityAbgeschlossen
-
Shaare Zedek Medical CenterUnbekanntPrämenstruelles Syndrom-PMS
-
Esra ÖZERKTO Karatay UniversityRekrutierungPrämenstruelles Syndrom-PMSTruthahn
-
Assistance Publique - Hôpitaux de ParisRekrutierungIntensivstation-Syndrom | Pädiatrisches Post-Intensivpflege-SyndromFrankreich
-
Riphah International UniversityRekrutierungUpper-Cross-SyndromPakistan
-
Cairo UniversityNoch keine Rekrutierung
-
Cairo UniversityRekrutierung
-
Riphah International UniversityAbgeschlossenUpper-Cross-SyndromPakistan
Klinische Studien zur Weight reduction regimen
-
SolitonEmergent Clinical Consulting, LLCAbgeschlossen
-
University of California, San FranciscoAbgeschlossenDepression | Angst | TinnitusVereinigte Staaten
-
The Miriam HospitalAbgeschlossenFettleibigkeit | ÜbergewichtVereinigte Staaten
-
University of California, San FranciscoZurückgezogenKrankhafte FettsuchtVereinigte Staaten
-
Vanderbilt University Medical CenterAbgeschlossenDepression | Betonen | Ausbrennen | Angst | SelbstmitgefühlVereinigte Staaten
-
University of ConnecticutWeight Watchers InternationalAbgeschlossenÜbergewicht und Adipositas
-
Dartmouth-Hitchcock Medical CenterHitchcock FoundationAbgeschlossenDepression | FettleibigkeitVereinigte Staaten
-
University of PennsylvaniaWeight Watchers InternationalAbgeschlossenÜbergewicht und AdipositasVereinigte Staaten
-
Indiana UniversityIndiana Clinical and Translational Sciences Institute; Weight Watchers International und andere MitarbeiterAbgeschlossenFettleibigkeit | Prädiabetes | Schwangerschaftsdiabetes mellitusVereinigte Staaten
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Aktiv, nicht rekrutierend